NASDAQ · NEOG
Healthcare · Medical - Diagnostics & Research
$11.82
Down-$0.44 (-3.59%)
Updated Oct 31, 2026, 6:13 PM
SID Score
5.7/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance · NEOG
1M range · 21 trading sessions · Daily adjusted prices
Prices through Oct 30, 2026
NEOG closed at $11.82 after 21 trading sessions, down 2.72% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 30, 2026 | $12.15 | $12.24 | $11.63 | $11.82 | 1.95M |
| Oct 29, 2026 | $12.24 | $12.37 | $12.05 | $12.26 | 3.23M |
| Oct 28, 2026 | $12.36 | $12.845 | $12.035 | $12.12 | 3.64M |
| Oct 27, 2026 | $12.26 | $12.6025 | $12.17 | $12.47 | 3.31M |
| Oct 26, 2026 | $12.20 | $12.35 | $12.11 | $12.21 | 1.69M |
| Oct 23, 2026 | $11.97 | $12.34 | $11.82 | $12.19 | 2.65M |
| Oct 22, 2026 | $11.78 | $12.145 | $11.765 | $11.98 | 2.88M |
| Oct 21, 2026 | $11.63 | $11.925 | $11.63 | $11.79 | 2.12M |
| Oct 20, 2026 | $11.66 | $11.84 | $11.5911 | $11.72 | 2.32M |
| Oct 19, 2026 | $11.92 | $11.95 | $11.605 | $11.63 | 3.42M |
| Oct 16, 2026 | $12.27 | $12.45 | $11.68 | $11.81 | 2.46M |
| Oct 15, 2026 | $12.01 | $12.35 | $11.85 | $12.27 | 2.88M |
| Oct 14, 2026 | $11.54 | $12.15 | $11.50 | $12.13 | 3.35M |
| Oct 13, 2026 | $11.99 | $12.06 | $11.71 | $11.73 | 2.34M |
| Oct 12, 2026 | $11.99 | $12.11 | $11.76 | $12.00 | 2.57M |
| Oct 9, 2026 | $11.71 | $12.1086 | $11.57 | $11.85 | 3.65M |
| Oct 8, 2026 | $11.50 | $12.21 | $11.1337 | $11.71 | 8.67M |
| Oct 7, 2026 | $12.61 | $12.925 | $11.37 | $11.68 | 12.97M |
| Oct 6, 2026 | $13.06 | $13.22 | $11.86 | $11.96 | 5.97M |
| Oct 5, 2026 | $12.02 | $13.06 | $11.98 | $13.01 | 5.15M |
| Oct 2, 2026 | $12.40 | $12.50 | $12.13 | $12.15 | 2.88M |
The latest Smart Investors Daily articles mentioning NEOG.
Company
Market Activity
Research & News
NEOG research
Company profile and research snapshot.
Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety, the company performs diagnostics to detect unintended substances in food and animal feed, to prevent contamination and foodborne illnesses such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, and ruminant by-products. In animal safety, the company segment is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products and genomics testing services.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Sep 30, 2026 | Guggenheim | Buy | — |
| Aug 26, 2026 | Piper Sandler | Overweight | — |
| Aug 3, 2026 | Piper Sandler | Neutral | — |
| Jan 12, 2026 | Piper Sandler | Neutral | — |
| Jan 9, 2026 | Guggenheim | Buy | — |
No generated briefing is available yet.
Yahoo · Oct 24, 2026
Neogen’s 25.9% return over the past six months has outpaced the S&P 500 by 16.8%, and its stock price has climbed to $11.78 per share. This was partly thanks to its solid quarterly results, and the run-up might have investors contemplating their next move.
Yahoo · Oct 20, 2026
Neogen beats Where Food Comes From in revenue growth and recovery potential, but higher debt and integration risks complicate the food safety stock showdown.
Yahoo · Oct 19, 2026
Life sciences company Neogen (NASDAQ:NEOG) reported calendar Q3 2026 (fiscal Q1 2027) results beating Wall Street’s revenue expectations, with sales up 6.5% year on year to $222.8 million. The company expects the full year’s revenue to be around $887.5 million, close to analysts’ estimates. Its non-GAAP profit of $0.08 per share was 50% above analysts’ consensus estimates.
Yahoo · Oct 13, 2026
After a summer of food recalls and illness outbreaks, Neogen CEO Mike Nassif explains how testing, traceability,and data can help producers spot risks earlier and rebuild consumer confidence in a complex global food supply chain.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning NEOG.
